Q5009 HCPCS code: Hospice or home health care provided in place not otherwise specified (nos)
Q5009 is the HCPCS Level II code for hospice or home health care provided in place not otherwise specified (nos). Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | Q codes — Temporary codes |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | Y2 |
| Added | 2007-01-01 |
| Last action effective | 2013-07-01 |
What changed for Q5009
- 2007-01-01: Q5009 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code Q5009?
Q5009 is the HCPCS Level II code for hospice or home health care provided in place not otherwise specified (nos). Short descriptor: "Hospice/home hlth, place nos".
Does Medicare cover Q5009?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related Q50 codes
- Q5001 — Hospice or home health care provided in patient's home/residence
- Q5002 — Hospice or home health care provided in assisted living facility
- Q5003 — Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
- Q5004 — Hospice care provided in skilled nursing facility (snf)
- Q5005 — Hospice care provided in inpatient hospital
- Q5006 — Hospice care provided in inpatient hospice facility
- Q5007 — Hospice care provided in long term care facility
- Q5008 — Hospice care provided in inpatient psychiatric facility
- Q5010 — Hospice home care provided in a hospice facility
- Q5098 — Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
- Q5099 — Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under Q5009
- Watch Q5009 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for Q5009
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.